148 related articles for article (PubMed ID: 20508288)
1. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
[TBL] [Abstract][Full Text] [Related]
2. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Hu K; Yao X
Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
[TBL] [Abstract][Full Text] [Related]
4. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
[TBL] [Abstract][Full Text] [Related]
6. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
8. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
J Med Chem; 2012 Oct; 55(20):8630-41. PubMed ID: 22992049
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Anticancer Activity, and Apoptosis Induction of Novel 3,6-Diazaphenothiazines.
Morak-Młodawska B; Pluta K; Latocha M; Jeleń M; Kuśmierz D
Molecules; 2019 Jan; 24(2):. PubMed ID: 30642021
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties.
Luzina EL; Popov AV
Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of angularly condensed diquinothiazines as potential anticancer agents.
Jeleń M; Pluta K; Latocha M; Morak-Młodawska B; Suwińska K; Kuśmierz D
Bioorg Chem; 2019 Jun; 87():810-820. PubMed ID: 30981160
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of novel selective antitumor constituents, sidrin and sidroside, from
Mostafa MAH; Khojah HMJ; Ohta T
Saudi Pharm J; 2023 Jun; 31(6):1019-1028. PubMed ID: 37234346
[TBL] [Abstract][Full Text] [Related]
17. 3-(4-chlorophenyl)-[1, 2, 3] oxadiazol-3-ium-5-olate and its 4-formyl analog-Ultrasound assisted synthesis and in-vitro anticancer evaluation against human tumor cell lines.
Bhosale SK; Deshpande SR; Wagh RD
Pak J Pharm Sci; 2017 Mar; 30(2):513-520. PubMed ID: 28649078
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro.
Hu K; Yao XS
Anticancer Res; 2002; 22(2A):1001-5. PubMed ID: 12014616
[TBL] [Abstract][Full Text] [Related]
19. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
Hu K; Yao X
Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
[TBL] [Abstract][Full Text] [Related]
20. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]